[Subacute cutaneous lupus erythematosus induced by golimumab]

Med Clin (Barc). 2015 Sep 7;145(5):226-7. doi: 10.1016/j.medcli.2014.10.013. Epub 2014 Dec 26.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / etiology*
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Drug Therapy, Combination
  • Female
  • Humans
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Lupus Erythematosus, Cutaneous / chemically induced*
  • Lupus Erythematosus, Cutaneous / pathology
  • Middle Aged
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Isoxazoles
  • Tumor Necrosis Factor-alpha
  • golimumab
  • Leflunomide